Fortive Corporation Common Stock vs QXO Inc. Common Stock — how do they compare? Fortive Corporation Common Stock trades at $57.21 (market cap $17.29B), while QXO Inc. Common Stock trades at $10.39 (market cap $10.72B). The key difference: Fortive Corporation Common Stock is the larger of the two by market cap, and Fortive Corporation Common Stock pays a 0.49% dividend while QXO Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fortive Corporation Common Stock for 6 Days and QXO Inc. Common Stock for 0 Days on average.
| FTV | QXO | |
|---|---|---|
Market Cap | $17.29B | $10.72B |
Volume | 2,129,605 | 34,000,619 |
Sector | Technology | Industrials |
52-Week High | $64.09 | $27.07 |
52-Week Low | $48.49 | $10.33 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $20.42B | $16.04B |
Dividend Yield | 0.49% | — |
Signals from Pluang's Aura AI — not financial advice
Fortive Corporation (FTV) trades at $58.07, up 1.22% today, with a neutral technical signal and a consensus analyst price target of $63.33. The stock shows strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue growth is modest, but profitability remains solid with a 12.38% net income margin. Recent news highlights product launches and a dividend increase, while institutional activity includes mixed buying and selling.
The outlook is cautiously positive, supported by raised 2026 guidance and core growth acceleration. Key risks include competitive pressures and macroeconomic headwinds. Analyst sentiment is mixed, with 36.67% buy ratings, but the stock offers potential upside to the consensus target if execution continues to improve.
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Fortive provides industrial and healthcare technology solutions. Its products and software support measurement, maintenance, worker safety, instrument sterilization, and clinical workflows.
Read more on FTV →QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →